232 related articles for article (PubMed ID: 27250643)
1. Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody.
Sugata K; Yasunaga J; Miura M; Akari H; Utsunomiya A; Nosaka K; Watanabe Y; Suzushima H; Koh KR; Nakagawa M; Kohara M; Matsuoka M
Sci Rep; 2016 Jun; 6():27150. PubMed ID: 27250643
[TBL] [Abstract][Full Text] [Related]
2. Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection.
Miura M; Yasunaga J; Tanabe J; Sugata K; Zhao T; Ma G; Miyazato P; Ohshima K; Kaneko A; Watanabe A; Saito A; Akari H; Matsuoka M
Retrovirology; 2013 Oct; 10():118. PubMed ID: 24156738
[TBL] [Abstract][Full Text] [Related]
3. Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.
Castro I; Giret TM; Magnani DM; Maxwell HS; Umland O; Perry JK; Pecotte JK; Brasky KM; Barber GN; Desrosiers RC; Watkins DI
J Virol; 2016 Jun; 90(11):5280-5291. PubMed ID: 26984729
[TBL] [Abstract][Full Text] [Related]
4. Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.
Yamauchi J; Coler-Reilly A; Sato T; Araya N; Yagishita N; Ando H; Kunitomo Y; Takahashi K; Tanaka Y; Shibagaki Y; Nishioka K; Nakajima T; Hasegawa Y; Utsunomiya A; Kimura K; Yamano Y
J Infect Dis; 2015 Jan; 211(2):238-48. PubMed ID: 25104771
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1.
Ibrahim F; de Thé G; Gessain A
J Virol; 1995 Nov; 69(11):6980-93. PubMed ID: 7474117
[TBL] [Abstract][Full Text] [Related]
6. Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T; Coler-Reilly ALG; Yagishita N; Araya N; Inoue E; Furuta R; Watanabe T; Uchimaru K; Matsuoka M; Matsumoto N; Hasegawa Y; Yamano Y
N Engl J Med; 2018 Feb; 378(6):529-538. PubMed ID: 29414279
[TBL] [Abstract][Full Text] [Related]
7. High simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeys.
Gabet AS; Gessain A; Wattel E
Int J Cancer; 2003 Oct; 107(1):74-83. PubMed ID: 12925959
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a HTLV-1 subunit vaccine in prevention of experimental STLV-I infection in Macaca nemestrina.
Dezzutti CS; Frazier DE; Lafrado LJ; Olsen RG
J Med Primatol; 1990; 19(3-4):305-16. PubMed ID: 2172541
[TBL] [Abstract][Full Text] [Related]
9. HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation.
Sugata K; Yasunaga J; Kinosada H; Mitobe Y; Furuta R; Mahgoub M; Onishi C; Nakashima K; Ohshima K; Matsuoka M
Cancer Res; 2016 Sep; 76(17):5068-79. PubMed ID: 27402079
[TBL] [Abstract][Full Text] [Related]
10. Immune recognition of genetically diverse simian T-cell lymphotropic virus type I isolates.
Lazo A; Bailer RT; Blakeslee JR; Yanagihara R; Stevens VC; Kramer L; Lairmore MD
Arch Virol; 1995; 140(2):307-23. PubMed ID: 7535998
[TBL] [Abstract][Full Text] [Related]
11. Simian T Lymphotropic Virus 1 Infection of Papio anubis:
Termini JM; Magnani DM; Maxwell HS; Lauer W; Castro I; Pecotte J; Barber GN; Watkins DI; Desrosiers RC
J Virol; 2017 Oct; 91(20):. PubMed ID: 28724769
[TBL] [Abstract][Full Text] [Related]
12. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
[TBL] [Abstract][Full Text] [Related]
13. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells.
Hieshima K; Nagakubo D; Nakayama T; Shirakawa AK; Jin Z; Yoshie O
J Immunol; 2008 Jan; 180(2):931-9. PubMed ID: 18178833
[TBL] [Abstract][Full Text] [Related]
14. Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
Hiyoshi M; Okuma K; Tateyama S; Takizawa K; Saito M; Kuramitsu M; Araki K; Morishita K; Okada S; Yamamoto N; Biragyn A; Yamaguchi K; Hamaguchi I
Retrovirology; 2015 Aug; 12():73. PubMed ID: 26289727
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of an HTLV-1 subunit vaccine in prevention of a STLV-1 infection in pig-tailed macaques.
Dezzutti CS; Frazier DE; Olsen RG
Dev Biol Stand; 1990; 72():287-96. PubMed ID: 2178125
[TBL] [Abstract][Full Text] [Related]
16. Dynamic interaction between STLV-1 proviral load and T-cell response during chronic infection and after immunosuppression in non-human primates.
Souquière S; Mouinga-Ondemé A; Makuwa M; Hermine O; Kazanji M
PLoS One; 2009 Jun; 4(6):e6050. PubMed ID: 19557183
[TBL] [Abstract][Full Text] [Related]
17. Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas.
Remer M; Al-Shamkhani A; Glennie M; Johnson P
Immunotherapy; 2014; 6(11):1187-206. PubMed ID: 25496334
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL responses.
Hasegawa A; Murata M; Fujikawa T; Katagiri K; Nagano Y; Masuda T; Kuramitsu M; Nakajima S; Fujisawa JI; Okuma K; Grover P; Kidiga M; Akari H; Kannagi M
PLoS Pathog; 2023 Feb; 19(2):e1011104. PubMed ID: 36730466
[TBL] [Abstract][Full Text] [Related]
19. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.
Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA
Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389
[TBL] [Abstract][Full Text] [Related]
20. Clinical Application of Anti-CCR4 Monoclonal Antibody.
Ueda R
Oncology; 2015; 89 Suppl 1():16-21. PubMed ID: 26550987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
